Tirzepatide vs semaglutide: A head-to-head comparison for management of obesity

A/Prof Samantha Hocking

writer

A/Prof Samantha Hocking

Endocrinologist; Royal Prince Alfred Hospital; Clinical Academic at Charles Perkins Research Centre, University of Sydney; President, National Association of Clinical Obesity Services (NACOS)

Claim CPD for this activity

Educational Activities (EA)

0.5 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0.5 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

1 hours

These are activities that use your work data to ensure quality results.

EA
0.5 minutes

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0.5 minutes

These are activities that require reflection on feedback about your work.

MO
1 minutes

These are activities that use your work data to ensure quality results.

The SURMOUNT-5 trial has provided definitive evidence that tirzepatide is superior to semaglutide for obesity treatment, achieving an additional 6.5% body weight reduction and nearly doubling the proportion of patients who lose 25% or more of their body weight.

This landmark head-to-head comparison, recently presented at the European Congress of Obesity in Spain, represents the first direct evidence comparing these two leading obesity medications helping to guide optimal treatment selection.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

References

N Engl J Med 2021;384:989-1002 (STEP 1)
N Engl J Med 2022;387:205-216 (SURMOUNT-1)
N Engl J Med 2025;393:26-36 (SURMOUNT-5)

Further your CPD learning

Based on this educational activity, complete these learning modules to gain additional CPD.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Li-Chuen Wong

A/Prof Li-Chuen Wong

Eczema Practical Updates for General Practice

Dr Preeti Joshi

Dr Preeti Joshi

Cow’s Milk Allergy in Infants and Children

A/Prof Michael Woodward AM

A/Prof Michael Woodward AM

RSV Vaccine on the NIP – What You Need to Know

Clinical A/Prof Greg Katsoulotos

Clinical A/Prof Greg Katsoulotos

Inhaler Devices Workshop

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

A/Prof Samantha Hocking

writer

A/Prof Samantha Hocking

Endocrinologist; Royal Prince Alfred Hospital; Clinical Academic at Charles Perkins Research Centre, University of Sydney; President, National Association of Clinical Obesity Services (NACOS)

Test your knowledge

Recent articles

Latest GP poll

Mark Butler says 50% of practices are now bulk billing. To what extent does this match with your observation within the profession?

Overestimated

0%

Accurate

0%

Technically accurate but misleading

0%

Underestimated

0%

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

Eczema Practical Updates for General Practice

Tuesday 12th May, 7pm - 9pm AEST

Speaker

A/Prof Li-Chuen Wong

Consultant Dermatologist; Senior Specialist Visiting Medical Officer, Head, Dermatology Department, Children's Hospital at Westmead

In this talk, Associate Professor Li-Chuen Wong will outline a practical, structured approach to managing these patients. We invite you to join the next Healthed webcast.